Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT05338879 · COMPLETED
Trial details
- NCT number
- NCT05338879
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-22
- Primary completion
- 2023-10-05
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.